Page last updated: 2024-12-11

4-oxo-(e)-2-hexenal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-oxo-(E)-2-hexenal: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(E)-4-oxohex-2-enal : The enal that is (E)-hex-2-enal substituted with an oxo group at C-4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6365145
CHEBI ID76721
SCHEMBL ID1270742
MeSH IDM0493492

Synonyms (29)

Synonym
OHE ,
4-oxo-2e-hexenal
LMFA06000120
AKOS006289522
(e)-4-oxohex-2-enal
(e)-4-oxo-2-hexenal
2492-43-5
2-hexenal, 4-oxo-, (e)-
(2e)-4-oxohex-2-enal
CHEBI:76721
4-oxo-2-hexenal
SCHEMBL1270742
GVKYFODEMNCLGS-ONEGZZNKSA-N
(e)-4-oxo-2-hexen-1-al
4-oxo-(e)-2-hexenal
Q27146302
mfcd08690491
2-hexenal, 4-oxo-, (2e)-
DTXSID701315637
20697-55-6
(2e)-4-oxo-2-hexenal
trans-4-ketohex-2-enal
trans-4-oxohex-2-en-1-al
4-oxo-e-2-hexenal
4-oxo-trans-2-hexenal
4-oxohex-2-enal
trans-4-oxo-2-hexenal
4MT6VG8ZKR
4-oxidanylidenehex-2-enal
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
enalAn alpha,beta-unsaturated aldehyde of general formula R(1)R(2)C=CR(3)-CH=O in which the aldehydic C=O function is conjugated to a C=C double bond at the alpha,beta position.
enoneAn alpha,beta-unsaturated ketone of general formula R(1)R(2)C=CR(3)-C(=O)R(4) (R(4) =/= H) in which the C=O function is conjugated to a C=C double bond at the alpha,beta position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (35.71)29.6817
2010's9 (64.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.68 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.44 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]